Variables | Number (n) | Percentage (%) |
---|---|---|
Level of the collaboration (n = 20) | ||
International | 9 | 45 |
Federal | 4 | 20 |
Provincial | 4 | 20 |
Local | 1 | 5 |
Missing | 2 | 10 |
Year of implementation (n = 20) | ||
2010 | 4 | 20 |
2011 | 3 | 15 |
2014 | 2 | 10 |
2012 | 1 | 5 |
2009 | 1 | 5 |
2008 | 1 | 5 |
2002 | 1 | 5 |
1999 | 1 | 5 |
1998 | 1 | 5 |
1967 | 1 | 5 |
Missing | 4 | 20 |
Funding sources (n = 20) | ||
Public and Private | 11 | 55 |
Public | 3 | 15 |
Missing | 6 | 30 |
Structure**** (n = 20) | ||
Network structure | 7 | 35 |
Hierarchical structure | 6 | 30 |
Divisional structure | 3 | 15 |
Team-based organizational Structure | 3 | 15 |
Missing | 1 | 5 |
Location (n = 20) | ||
Physical and Virtual sites | 10 | 50 |
Physical site | 3 | 15 |
Virtual site | 2 | 10 |
Missing | 5 | 25 |
Clinical focus (n = 20) | ||
Cardiovascular diseases | 5 | 25 |
Mixed** | 4 | 20 |
Cancer | 3 | 75 |
Cardiovascular diseases | 3 | 75 |
Brain glioma | 1 | 25 |
Chronic metabolic diseases | 1 | 25 |
Diabetes | 1 | 25 |
Endocrine and metabolic diseases | 1 | 25 |
Gerontology | 1 | 25 |
Hemopoietic disease | 1 | 25 |
HIV/AIDS | 1 | 25 |
Inflammatory diseases | 1 | 25 |
Kidney disease | 1 | 25 |
Obesity | 1 | 25 |
Neuropsychological disease | 1 | 25 |
Psychosomatic diseases | 1 | 25 |
Reproductive health | 1 | 25 |
Trauma | 1 | 25 |
Visual reconstruction | 1 | 25 |
Cardiovascular disease complications | 1 | 5 |
Diabetes | 1 | 5 |
Diabetes complications | 1 | 5 |
Gerontology | 1 | 5 |
Neurological diseases | 1 | 5 |
Brain diseases | 1 | 5 |
Missing | 5 | 25 |
Goal (n = 20) | ||
Mixed** | 19 | 95 |
To improve biomedical research | 17 | 89 |
To promote collaborative practices | 14 | 74 |
To promote the translation between research and clinical practice | 14 | 74 |
To support patient treatment | 11 | 58 |
To improve clinical practices | 8 | 42 |
To help prevent diseases | 6 | 32 |
To ensure equitable benefit from scientific evidence | 1 | 5 |
To promote collaborative practices | 1 | 5 |
Type of interaction between the people involved (n = 20) | ||
Mixed** | 18 | 90 |
Collaboration | 18 | 100 |
Partnership | 18 | 100 |
Information | 7 | 39 |
Consultation | 4 | 22 |
Collaboration | 1 | 5 |
Missing | 1 | 5 |
Governance (n = 20)***** | ||
Central governance | 9 | 45 |
Multi-level governance | 2 | 10 |
Public governance | 1 | 5 |
Missing | 8 | 40 |